Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · SBC Medical Group Holdings Inc (SBC)

SBC Medical Group: Director Mike Sayama Will Not Seek Re-Election at 2026 AGM

Neutral Impact 2 of 5 leadership Written later

Independent director Mike Sayama notified SBC Medical Group on May 14, 2026, that he will not seek re-election at the 2026 Annual Meeting of Stockholders. The board reduced its size to four members effective before the polls open at that meeting, and it plans to search for a fifth independent director to join after the meeting. The filing says Mr. Sayama's decision did not stem from any disagreement with the company, its management, or the board on operations, policies or practices.

Key points

  • Mike Sayama, an independent director, notified the company on May 14, 2026 that he will not seek re-election.
  • Board size will be reduced to four members, effective immediately before the polls open at the 2026 AGM.
  • The board is searching for a fifth independent director; it intends to appoint that person to the nominating and governance, compensation and audit committees, replacing Mr. Sayama's committee seats.

The filing

CompanySBC Medical Group Holdings Inc (SBC)
Form8-K, current report
Filed with the SECMay 20, 2026, 4:15 PM ET
Accession number0001493152-26-024609

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 20, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.